✔ Clinically proven effectiveness in weight reduction.
✔ Suitable for individuals with obesity and metabolic disorders.
✔ Convenient once-weekly injection.
✔ Supports overall health, reducing the risk of cardiovascular diseases.
99.9% bioavailability
Updated handle
No preservatives
A Breakthrough in Weight Loss: An Innovative Incretin-Based Medication.
As part of the incretin-based drug class, it uniquely activates both GIP and GLP-1 receptors, leading to appetite suppression, improved gastrointestinal metabolic processes, and optimized glucose metabolism.
Obesity (BMI ≥30 kg/m²).
Overweight (BMI ≥27 kg/m²) with metabolic conditions such as type 2 diabetes, hypertension, or dyslipidemia.
Tirzepatide is administered subcutaneously once a week, with dosage determined individually by a healthcare professional.
⚠ Warning!
A medical consultation is required before starting Tirzepatide to establish the appropriate dosage and assess any potential contraindications.
Tirzepatide – A Modern Approach to Weight Loss and Overall Well-Being!